Literature DB >> 24508730

Diverse macrophage populations mediate acute lung inflammation and resolution.

Neil R Aggarwal1, Landon S King, Franco R D'Alessio.   

Abstract

Acute respiratory distress syndrome (ARDS) is a devastating disease with distinct pathological stages. Fundamental to ARDS is the acute onset of lung inflammation as a part of the body's immune response to a variety of local and systemic stimuli. In patients surviving the inflammatory and subsequent fibroproliferative stages, transition from injury to resolution and recovery is an active process dependent on a series of highly coordinated events regulated by the immune system. Experimental animal models of acute lung injury (ALI) reproduce key components of the injury and resolution phases of human ARDS and provide a methodology to explore mechanisms and potential new therapies. Macrophages are essential to innate immunity and host defense, playing a featured role in the lung and alveolar space. Key aspects of their biological response, including differentiation, phenotype, function, and cellular interactions, are determined in large part by the presence, severity, and chronicity of local inflammation. Studies support the importance of macrophages to initiate and maintain the inflammatory response, as well as a determinant of resolution of lung inflammation and repair. We will discuss distinct roles for lung macrophages during early inflammatory and late resolution phases of ARDS using experimental animal models. In addition, each section will highlight human studies that relate to the diverse role of macrophages in initiation and resolution of ALI and ARDS.

Entities:  

Keywords:  ARDS; activation; inflammation; macrophage

Mesh:

Year:  2014        PMID: 24508730      PMCID: PMC3989724          DOI: 10.1152/ajplung.00341.2013

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  206 in total

1.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

2.  A study of the origin of pulmonary macrophages using the Chédiak-Higashi marker.

Authors:  K J Johnson; P A Ward; G Striker; R Kunkel
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

3.  Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.

Authors:  Andrew J Thorley; Paul A Ford; Mark A Giembycz; Peter Goldstraw; Alan Young; Teresa D Tetley
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

4.  New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.

Authors:  Lei Sun; Marisa C Louie; Kevin M Vannella; Carol A Wilke; Ann Marie LeVine; Bethany B Moore; Thomas P Shanley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-03       Impact factor: 5.464

5.  Direct evidence for a bone marrow origin of the alveolar macrophage in man.

Authors:  E D Thomas; R E Ramberg; G E Sale; R S Sparkes; D W Golde
Journal:  Science       Date:  1976-06-04       Impact factor: 47.728

6.  GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice.

Authors:  J A Huffman Reed; W R Rice; Z K Zsengellér; S E Wert; G Dranoff; J A Whitsett
Journal:  Am J Physiol       Date:  1997-10

7.  Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase.

Authors:  K S Farley; L Wang; S Mehta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-12       Impact factor: 5.464

8.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

9.  The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice.

Authors:  Ulrich Maus; Karen von Grote; William A Kuziel; Matthias Mack; Edmund J Miller; Josef Cihak; Manfred Stangassinger; Regina Maus; Detlef Schlöndorff; Werner Seeger; Jürgen Lohmeyer
Journal:  Am J Respir Crit Care Med       Date:  2002-08-01       Impact factor: 21.405

10.  Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state.

Authors:  Matthew M Meredith; Kang Liu; Alice O Kamphorst; Juliana Idoyaga; Arito Yamane; Pierre Guermonprez; Suzannah Rihn; Kai-Hui Yao; Israel T Silva; Thiago Y Oliveira; Dimitris Skokos; Rafael Casellas; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2012-07-30       Impact factor: 14.307

View more
  203 in total

1.  Sodium-activated macrophages: the salt mine expands.

Authors:  Liliana E Lucca; David A Hafler
Journal:  Cell Res       Date:  2015-07-28       Impact factor: 25.617

Review 2.  Platelets in the pathogenesis of acute respiratory distress syndrome.

Authors:  Hemang Yadav; Daryl J Kor
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-28       Impact factor: 5.464

3.  Single cell RNA sequencing identifies an early monocyte gene signature in acute respiratory distress syndrome.

Authors:  Yale Jiang; Brian R Rosborough; Jie Chen; Sudipta Das; Georgios D Kitsios; Bryan J McVerry; Rama K Mallampalli; Janet S Lee; Anuradha Ray; Wei Chen; Prabir Ray
Journal:  JCI Insight       Date:  2020-07-09

4.  Regulation of ozone-induced lung inflammation and injury by the β-galactoside-binding lectin galectin-3.

Authors:  Vasanthi R Sunil; Mary Francis; Kinal N Vayas; Jessica A Cervelli; Hyejeong Choi; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-25       Impact factor: 4.219

5.  In vivo and in vitro inflammatory responses to fine particulate matter (PM2.5) from China and California.

Authors:  Wanjun Yuan; Ciara C Fulgar; Xiaolin Sun; Christoph F A Vogel; Ching-Wen Wu; Qi Zhang; Keith J Bein; Dominique E Young; Wei Li; Haiying Wei; Kent E Pinkerton
Journal:  Toxicol Lett       Date:  2020-04-19       Impact factor: 4.372

Review 6.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

Review 7.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

Review 8.  The amount of cytokine-release defines different shades of Sars-Cov2 infection.

Authors:  S Bindoli; M Felicetti; P Sfriso; A Doria
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-28

9.  IL-1β and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development.

Authors:  Ashley N Stouch; Alyssa M McCoy; Rachel M Greer; Omar Lakhdari; Fiona E Yull; Timothy S Blackwell; Hal M Hoffman; Lawrence S Prince
Journal:  J Immunol       Date:  2016-03-07       Impact factor: 5.422

10.  Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils.

Authors:  Maud Deny; Marta Romano; Olivier Denis; Georges Casimir; Mustapha Chamekh
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.